PSCA Antibodies

Santa Cruz Biotechnology features a diverse variety of PSCA monoclonal antibodies for applications including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PSCA, or Prostate Stem Cell Antigen, is a glycoprotein that plays a significant role in the regulation of cell growth and differentiation, particularly in prostate cancer. PSCA expression is often associated with tumor progression, making it a critical target for cancer diagnostics and therapeutics. Understanding PSCA function and regulation is essential for advancing prostate cancer research and treatment development. PSCA expression patterns can serve as valuable biomarkers for disease progression and treatment response. Investigating PSCA signaling pathways helps reveal mechanisms underlying cancer development and metastasis. Molecular analysis of PSCA interactions provides insights into potential therapeutic interventions. Research utilizing PSCA monoclonal antibodies from Santa Cruz Biotechnology continues to advance scientific understanding of prostate cancer biology and support the development of innovative treatment strategies.